The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.
Results from the first phase of the clinical trial of an Ebola vaccine suggests it is safe to use, Chinese scientists say.
Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.
One Chinese lie has been finally nailed this time by a team of Indian scientists who provide irrefutable evidence that rice did originate in India, a fact contested by China.
'If we play our cards right, we may even benefit from the competition between the US and China as seen from increased investment from each of these countries into India.' 'The size of our market gives us an important lever of power which we shall have to play adroitly and intelligently,' points out Ambassador Gautam Bambawale -- who served as India's envoy to China -- in the Professor V M Dandekar Memorial Lecture 2019, delivered on March 8, 2019 in Pune.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances